Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the ...

Fly this December and receive exclusive wildlife-themed amenity kits, highlighting endangered species with eco-friendly ...

Fortress Biotech ( ($FBIO) ) has provided an announcement. On December 15, 2025, Fortress Biotech announced that the U.S. FDA accepted the ...

Cash deposits during demonetisation were held genuine where supported by EMI recoveries from thousands of borrowers, with no enquiry or evidence to treat them as ...